Barclays »

Akero Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.8M 246k 23.35
2023-09-30 $17M 340k 50.58
2023-06-30 $6.7M 143k 46.69
2023-03-31 $3.0M 77k 38.25
2022-12-31 $5.7M 104k 54.80
2022-09-30 $40k 1.2k 33.67
2022-06-30 $114k 12k 9.44
2022-03-31 $107k 7.6k 14.08
2021-12-31 $750k 35k 21.15
2021-09-30 $315k 14k 22.38
2021-06-30 $136k 5.5k 24.85
2021-03-31 $369k 13k 28.94
2020-12-31 $153k 5.9k 25.77
2020-09-30 $252k 8.2k 30.83
2020-06-30 $433k 17k 24.87
2020-03-31 $59k 2.8k 21.21
2019-12-31 $112k 5.0k 22.29
2019-09-30 $61k 2.7k 22.96